Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Unexpected maintenance of hepatitis C viral diversity following liver transplantation.

Gray RR, Strickland SL, Veras NM, Goodenow MM, Pybus OG, Lemon SM, Fried MW, Nelson DR, Salemi M.

J Virol. 2012 Aug;86(16):8432-9. doi: 10.1128/JVI.00749-12. Epub 2012 May 23.

2.

Characterization of Hepatitis C Virus (HCV) Envelope Diversification from Acute to Chronic Infection within a Sexually Transmitted HCV Cluster by Using Single-Molecule, Real-Time Sequencing.

Ho CK, Raghwani J, Koekkoek S, Liang RH, Van der Meer JT, Van Der Valk M, De Jong M, Pybus OG, Schinkel J, Molenkamp R.

J Virol. 2017 Feb 28;91(6). pii: e02262-16. doi: 10.1128/JVI.02262-16. Print 2017 Mar 15.

3.

Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation.

Fafi-Kremer S, Fofana I, Soulier E, Carolla P, Meuleman P, Leroux-Roels G, Patel AH, Cosset FL, Pessaux P, Doffoël M, Wolf P, Stoll-Keller F, Baumert TF.

J Exp Med. 2010 Aug 30;207(9):2019-31. doi: 10.1084/jem.20090766. Epub 2010 Aug 16.

4.

Liver transplantation with hepatitis C virus-infected graft: interaction between donor and recipient viral strains.

Fan X, Lang DM, Xu Y, Lyra AC, Yusim K, Everhart JE, Korber BT, Perelson AS, Di Bisceglie AM.

Hepatology. 2003 Jul;38(1):25-33.

PMID:
12829983
5.

Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation.

Arenas JI, Gallegos-Orozco JF, Laskus T, Wilkinson J, Khatib A, Fasola C, Adair D, Radkowski M, Kibler KV, Nowicki M, Douglas D, Williams J, Netto G, Mulligan D, Klintmalm G, Rakela J, Vargas HE.

J Infect Dis. 2004 Jun 1;189(11):2037-46. Epub 2004 May 10.

PMID:
15143471
6.

Dynamics of defective hepatitis C virus clones in reinfected liver grafts in liver transplant recipients: ultradeep sequencing analysis.

Ohtsuru S, Ueda Y, Marusawa H, Inuzuka T, Nishijima N, Nasu A, Shimizu K, Koike K, Uemoto S, Chiba T.

J Clin Microbiol. 2013 Nov;51(11):3645-52. doi: 10.1128/JCM.00676-13. Epub 2013 Aug 28.

7.

Early evolution of hepatitis C virus (HCV) quasispecies after liver transplant for HCV-related disease.

Schvoerer E, Soulier E, Royer C, Renaudin AC, Thumann C, Fafi-Kremer S, Brignon N, Doridot S, Meyer N, Pinson P, Ellero B, Woehl-Jaegle ML, Meyer C, Wolf P, Zachary P, Baumert T, Stoll-Keller F.

J Infect Dis. 2007 Aug 15;196(4):528-36. Epub 2007 Jun 29.

PMID:
17624837
8.

Early detection of hepatitis C allograft reinfection after orthotopic liver transplantation: a molecular and histologic study.

Guerrero RB, Batts KP, Burgart LJ, Barrett SL, Germer JJ, Poterucha JJ, Wiesner RH, Charlton MR, Persing DH.

Mod Pathol. 2000 Mar;13(3):229-37.

9.

Evolutionary dynamics of the E1-E2 viral populations during combination therapy in non-responder patients chronically infected with hepatitis C virus subtype 1b.

Saludes V, González-Candelas F, Planas R, Solà R, Ausina V, Martró E.

Infect Genet Evol. 2013 Jan;13:1-10. doi: 10.1016/j.meegid.2012.09.012. Epub 2012 Sep 26.

PMID:
23022712
10.

Quasispecies heterogeneity within the E1/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection.

Chambers TJ, Fan X, Droll DA, Hembrador E, Slater T, Nickells MW, Dustin LB, Dibisceglie AM.

J Virol. 2005 Mar;79(5):3071-83.

11.

Hepatitis C virus compartmentalization and infection recurrence after liver transplantation.

Ramirez S, Perez-Del-Pulgar S, Carrion JA, Costa J, Gonzalez P, Massaguer A, Fondevila C, Garcia-Valdecasas JC, Navasa M, Forns X.

Am J Transplant. 2009 Jul;9(7):1591-601. doi: 10.1111/j.1600-6143.2009.02666.x. Epub 2009 May 20.

12.

Sequence variation in the hypervariable region 1 of hepatitis C virus and posttransplantation recurrent hepatitis.

Silini E, Belli L, Brambilla S, Foti L, Gritti C, Lisa A, Alberti AB, Vinci M, De Carlis L, Rondinara G, Pinzello G.

Liver Transpl. 2003 Oct;9(10):1040-7.

13.

Quasispecies heterogeneity of the carboxy-terminal part of the E2 gene including the PePHD and sensitivity of hepatitis C virus 1b isolates to antiviral therapy.

Sarrazin C, Bruckner M, Herrmann E, Rüster B, Bruch K, Roth WK, Zeuzem S.

Virology. 2001 Oct 10;289(1):150-63.

14.

Evolutionary trends of the first hypervariable region of the hepatitis C virus E2 protein in individuals with differing liver disease severity.

Curran R, Jameson CL, Craggs JK, Grabowska AM, Thomson BJ, Robins A, Irving WL, Ball JK.

J Gen Virol. 2002 Jan;83(Pt 1):11-23.

PMID:
11752696
15.

Conservation of hepatitis C virus nonstructural protein 3 amino acid sequence in viral isolates during liver transplantation.

Mello IM, Thumann C, Schvoerer E, Soulier E, Pinho JR, Silvestre DA, Queiroz AT, Wolf P, Baumert TF, Keller FS, Pereira CA.

J Viral Hepat. 2009 Oct;16(10):732-7. doi: 10.1111/j.1365-2893.2009.01125.x. Epub 2009 Mar 25.

PMID:
19486468
16.

Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.

Pawlotsky JM, Pellerin M, Bouvier M, Roudot-Thoraval F, Germanidis G, Bastie A, Darthuy F, Rémiré J, Soussy CJ, Dhumeaux D.

J Med Virol. 1998 Apr;54(4):256-64.

PMID:
9557291
17.

Diversification of hypervariable region 1 of hepatitis C virus after liver transplantation.

Fan X, Di Bisceglie AM.

J Med Virol. 2003 Jun;70(2):212-8.

PMID:
12696107
18.
19.

The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies.

Farci P, Shimoda A, Coiana A, Diaz G, Peddis G, Melpolder JC, Strazzera A, Chien DY, Munoz SJ, Balestrieri A, Purcell RH, Alter HJ.

Science. 2000 Apr 14;288(5464):339-44.

20.

Genetic diversity of hepatitis C virus predicts recurrent disease after liver transplantation.

Li H, Sullivan DG, Feuerborn N, McArdle S, Bekele K, Pal S, Yeh M, Carithers RL, Perkins JD, Gretch DR.

Virology. 2010 Jul 5;402(2):248-55. doi: 10.1016/j.virol.2010.03.040. Epub 2010 Apr 18.

Supplemental Content

Support Center